Intranasal steroids and septum perforation - An overlooked complication? A description of the course of events and a discussion of the causes

Rhinology

Volumn 36, Issue 3, 1998, Pages 128-132

  Cervin, Anders ^a   Andersson, Morgan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Nasal septum; Perforation; Topical steroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUTICASONE PROPIONATE; HISTAMINE H1 RECEPTOR ANTAGONIST; NEDOCROMIL SODIUM; STEROID;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; NOSE INJURY; NOSE SEPTUM PERFORATION; RISK FACTOR; SINUSITIS; STEROID THERAPY;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AEROSOLS; AGED; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; BUDESONIDE; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NASAL SEPTUM; NOSE DISEASES; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; RHINITIS, VASOMOTOR; SEX FACTORS; SWEDEN; TIME FACTORS;

EID: 0031771958     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bende M, Lindqvist N, Pipkorn U (1983) Effect of a topical glucocorticoid, Budesonide on nasal mucosal blood flow as measured with 133Xe wash-out technique. Allergy 38: 461-464.
2. Gamboa PM, Jauregui I, Antepara I (1991) Contact dermatitis from budesonide in a nasal spray without cross-reactivity to amcinonide. Contact Dermatitis 24(3): 227-228.
3. Iglesias-Cadarso A, Diaz C, Laguna JJ, Hernandez-Weigand P (1994) Allergic contact dermatomucositis to budesonide. J Allergy Clin Immunol 94(3 Pt 1): 559-560.
4. Jerez J, Rodriguez F, Garces M, et al. (1990) Allergic contact dermatitis from budesonide. Contact Dermatitis 22(4): 231-232.
5. Schultz-Coulon HJ (1997) [Nasal septum repair-plasty with pedicled flap technique in 126 patients-an analysis]. Laryngorhinootologie 76:466-474.
6. Lindqvist N, Balle VH, Karma P, et al. (1986) Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis. Allergy 41: 179-186.
7. Lindqvist N, Holmberg K, Pipkorn U (1989) Intranasally administered budesonide, a glucocorticoid, does not exert its clinical effect through vasoconstriction. Clin Otolaryngol 14(6): 519-523.
8. Peris-Tortajada A, Giner A, Perez C, Hemandez D, Basomba A (1991) Contact allergy to topical budesonide. J Allergy Clin Immunol 87(2): 597-598.
9. Sastre J, Ibanez (1992) Contact allergy to budesonide contained in a nasal spray. Allergy 47 (6): 661-662.
10. Schoelzel EP, Menzel ML, Soderberg-Warner ML (1985) Nasal sprays and perforation of the nasal septumi Nasal septal perforation associated with topical corticosteroid therapy. Jama 253 (14): 2046.
11. Soderberg-Warner ML (1984) Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr 105(5): 840-841.
12. Thune P (1972) Plethysmographic recordings of skin pulses. IV: Further measurements of the vasoconstriction produced by corticosteroids. Acta Derm Venerol (Stockh) 52. 303.